What is Krystal Biotech, Inc.'s revenue?

Krystal Biotech, Inc. (KRYS) generated $417.3M in revenue over the trailing twelve months, up 25.1% year over year.

Is Krystal Biotech, Inc. profitable?

Krystal Biotech, Inc. reported $225.0M in net income over the trailing twelve months, a 53.9% net margin.

What is Krystal Biotech, Inc.'s earnings per share?

Krystal Biotech, Inc.'s diluted EPS over the trailing twelve months is $7.48.

Where does Krystal Biotech, Inc.'s income statement data come from?

Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Krystal Biotech, Inc. KRYS Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$116.36M+8.6%	$107.11M+9.5%	$97.8M+1.8%	$96.04M+8.9%	$88.18M-3.2%
Research and development	$15.33M+3.6%	$14.79M+1.4%	$14.59M+1.2%	$14.41M+1.1%	$14.26M+5.4%
Selling, general and administrative	$41.01M-1.0%	$41.45M+10.3%	$37.58M+6.9%	$35.16M+7.7%	$32.65M+4.3%
Total operating expenses	$62.67M-0.3%	$62.84M+11.4%	$56.43M-0.5%	$56.74M+9.3%	$51.93M+4.4%
Operating income	$53.69M+21.3%	$44.27M+7.0%	$41.37M+5.3%	$39.31M+8.4%	$36.25M-12.4%
Operating margin	46.1%+4.8pp	41.3%-1.0pp	42.3%+1.4pp	40.9%-0.2pp	41.1%-4.3pp
Interest expense	$7.75M+13.0%	$6.86M+4.1%	$6.59M-11.7%	$7.47M+1.7%	$7.35M+1.5%
Income before income taxes	$61.44M+20.2%	$51.13M+6.6%	$47.97M+2.5%	$46.78M+7.3%	$43.6M-10.3%
Income tax expense	$5.51M+2,148%	-$269K+99.1%	-$31.4M-472%	$8.44M+7.3%	$7.86M+151%
Net income	$55.93M+8.8%	$51.4M-35.2%	$79.37M+107%	$38.33M+7.3%	$35.73M-21.4%
Net margin	48.1%+0.1pp	48%-33.2pp	81.2%+41.2pp	39.9%-0.6pp	40.5%-9.4pp
Diluted earnings per share	$1.83+7.6%	$1.70-36.1%	$2.66+106%	$1.29+7.5%	$1.20-21.6%
EBITDA	$55.21M+20.5%	$45.83M+7.1%	$42.77M+5.3%	$40.61M+7.8%	$37.66M-11.9%
EBITDA margin	47.4%+4.7pp	42.8%-0.9pp	43.7%+1.5pp	42.3%-0.4pp	42.7%-4.2pp
EBIT	$53.69M+21.3%	$44.27M+7.0%	$41.37M+5.3%	$39.31M+8.4%	$36.25M-12.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Krystal Biotech, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Krystal Biotech, Inc.'s revenue?: Krystal Biotech, Inc. (KRYS) generated $417.3M in revenue over the trailing twelve months, up 25.1% year over year.
Is Krystal Biotech, Inc. profitable?: Krystal Biotech, Inc. reported $225.0M in net income over the trailing twelve months, a 53.9% net margin.
What is Krystal Biotech, Inc.'s earnings per share?: Krystal Biotech, Inc.'s diluted EPS over the trailing twelve months is $7.48.
Where does Krystal Biotech, Inc.'s income statement data come from?: Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.